EU lists uncommon nerve dysfunction as side-effect of J&J Covid-19 vaccine
1 min readFollowing a overview of 108 circumstances reported worldwide, Europe’s medicines regulator introduced on Thursday {that a} uncommon nerve-degeneration dysfunction, Guillain-Barré syndrome, had been added as a potential uncommon aspect impact of Johnson & Johnson’s Covid-19 vaccine.
